4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability

3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...

3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)

3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...

3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)

2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...

2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021

2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...

2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...

2/15/2022Snapshot of MNC Pharma's China Performance in 2021

2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...

2/9/2022GSK Reports Q4 and FY2021 Performance with China Related Mentions

2/8/2022Sanofi Reports Slowing Chinese Growth in Q4/2021

2/8/2022MSD's China Sales Skyrocketed Driven by Strong HPV Vaccine Growth

2/8/2022Novartis China Witness 10% Innovative Medicine Sales Growth in 2021 De...

2/7/2022Mybio Publishes the 2021 China Pharma BD Transactions Report

1/30/2022China Issues the 14th Five Year Plan for Pharmaceutical Industry Devel...

1/28/2022NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...

1/26/202293 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness

1/26/2022Information Collection on the 7th VBP Initiated at Numerous Provinces

1/18/2022Review of Chinese Pharmaceutical industry Performance Q1/2019-Q3/2021

1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...

1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ

1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...

1/5/2022Review of Chinese Pharma In-licensing Deals in 2021

1/5/2022China 2021: The NRDL Readout (PharmExec)

12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022

12/27/2021China's 2021 Negative Lists Widen Market Access for Foreign Investment...

Page:8/36 Total number of articles:1059: [First][<<] [6] [7] [8] [9] [10] [>>] [End]